Cannabis Shows Promise In Treating Schizophrenia

Doc

From 420 Magazine:  An experimental cannabis drug for treating schizophrenia, developed by UK-based GW Pharmaceuticals Plc, was found to be superior to a placebo in a mid-stage trial.

Read More From 420 Magazine:

Share this Post

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.